Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target.
The human pathogen Mycobacterium tuberculosis is the causative agent of pulmonary tuberculosis (TB), a disease with high worldwide mortality rates. Current treatment programs are under significant threat from multi-drug and extensively-drug resistant strains of M. tuberculosis, and it is essential t...
Main Authors: | Sudagar S Gurcha, Veeraraghavan Usha, Jonathan A G Cox, Klaus Fütterer, Katherine A Abrahams, Apoorva Bhatt, Luke J Alderwick, Robert C Reynolds, Nicholas J Loman, VijayaShankar Nataraj, Carlos Alemparte, David Barros, Adrian J Lloyd, Lluis Ballell, Judith V Hobrath, Gurdyal S Besra |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4237437?pdf=render |
Similar Items
-
Identification of novel Mt-Guab2 inhibitor series active against M. tuberculosis.
by: Veeraraghavan Usha, et al.
Published: (2012-01-01) -
Expression Pattern of the Aspartyl-tRNA Synthetase DARS in the Human Brain
by: Dominik Fröhlich, et al.
Published: (2018-03-01) -
Aspartyl tRNA-synthetase (AspRS) gene family enhances drought tolerance in poplar through BABA-PtrIBIs-PtrVOZ signaling module
by: Cong-Hua Feng, et al.
Published: (2023-08-01) -
The predatory bacterium Bdellovibrio bacteriovorus aspartyl-tRNA synthetase recognizes tRNAAsn as a substrate.
by: Ariel Alperstein, et al.
Published: (2014-01-01) -
DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
by: Katherine A. Abrahams, et al.
Published: (2023-06-01)